Ranbaxy posts 1,045 Crore net loss in 2008

Monday, 30 March 2009, 10:05 Hrs
Printer Print Email Email
Mumbai: Leading drug maker Ranbaxy Laboratories Monday reported a net loss of 1,044.8 crore ($204 million) for 2008 as against a net profit of 617.7 crore in the previous year.

However, the company's total income went up 9.85 percent to 4,681.7 crore in 2008 from 4,261.9 crore in 2007.

The group posted a consolidated net loss of 951.2 crore during the period, compared to a net profit of 774.5 crore in the previous calendar year.

The total consolidated income increased 11.2 percent to 7,691 crore from 6,917.2 crore, the company added.

Meanwhile, the drug major, which has been in trouble with the US Food and Drug Administration over alleged falsification of test results in approved and pending drug applications, Monday said the US drug regulator had given it the nod to sell topirimate tablets - a medication used for the treatment of seizures.

The drug is a generic version of epilepsy drug Topamax, owned by a unit of Johnson and Johnson.
Source: IANS
SPOTLIGHT
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..